These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27777160)

  • 1. Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2.
    Lawson McLean AC; Rosahl SK
    World Neurosurg; 2017 Feb; 98():152-161. PubMed ID: 27777160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
    Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
    J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth dynamics of intramedullary spinal tumors in patients with neurofibromatosis type 2.
    Lawson McLean AC; Rosahl SK
    Clin Neurol Neurosurg; 2016 Jul; 146():130-7. PubMed ID: 27208873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2.
    Osorio DS; Hu J; Mitchell C; Allen JC; Stanek J; Hagiwara M; Karajannis MA
    J Neurooncol; 2018 Sep; 139(3):749-755. PubMed ID: 29948766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-specific growth dynamics of neurofibromatosis type-2-related tumors of the central nervous system.
    Lawson McLean A; Rosahl S
    Acta Neurochir (Wien); 2016 Nov; 158(11):2127-2134. PubMed ID: 27590907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Diagnostic Dilemma: Multiple Primary Intracranial Tumors Without Vestibular Schwannomas.
    Faucett EA; Larsen BT; Khan R; Chiu AG; Chang EH
    Ann Otol Rhinol Laryngol; 2016 Nov; 125(11):938-942. PubMed ID: 27553596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial meningiomas and neurofibromatosis type 2.
    Aboukais R; Zairi F; Baroncini M; Bonne NX; Schapira S; Vincent C; Lejeune JP
    Acta Neurochir (Wien); 2013 Jun; 155(6):997-1001; discussion 1001. PubMed ID: 23558725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of multiple tumors in neurofibromatosis type 2 patients.
    Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
    Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.
    Picry A; Bonne NX; Ding J; Aboukais R; Lejeune JP; Baroncini M; Dubrulle F; Vincent C
    Laryngoscope; 2016 Oct; 126(10):2358-62. PubMed ID: 27075822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects.
    Slattery WH; Fisher LM; Iqbal Z; Oppenhiemer M
    Otol Neurotol; 2004 Sep; 25(5):811-7. PubMed ID: 15354016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
    Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
    Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment growth rate predicts radiation response in vestibular schwannomas.
    Niu NN; Niemierko A; Larvie M; Curtin H; Loeffler JS; McKenna MJ; Shih HA
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):113-9. PubMed ID: 24725695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series.
    Alanin MC; Klausen C; Caye-Thomasen P; Thomsen C; Fugleholm K; Poulsgaard L; Lassen U; Mau-Sorensen M; Hofland KF
    Int J Neurosci; 2016 Nov; 126(11):1002-6. PubMed ID: 26365467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.
    Nunes FP; Merker VL; Jennings D; Caruso PA; di Tomaso E; Muzikansky A; Barker FG; Stemmer-Rachamimov A; Plotkin SR
    PLoS One; 2013; 8(3):e59941. PubMed ID: 23555840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
    J Neurosurg; 2021 May; 134(5):1377-1385. PubMed ID: 32442973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.